UMIN ID: C000000414
Registered date:02/05/2006
Clinical study of adjuvant immuno-cell therapy for pancreatic cancer curatively resectable.
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | Pancreatic cancer |
Date of first enrollment | 2006/03/01 |
Target sample size | 10 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | Immuno-cell therapy(CD3-LAK) is done on day0, day14, day28, day42, day56, day70, day84, day98, day112. Gemcitabine is administered on day49, day63, day77, day91, day105, day119, day133, day147, day161, day175, day189, day203. |
Outcome(s)
Primary Outcome | Relapse-free survival rate of relapse |
---|---|
Secondary Outcome | Safety Overall survival QOL(KPS) Immunological parameter |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | 75years-old |
Gender | Male and Female |
Include criteria | |
Exclude criteria | Patients who have: uncontrolled infections, active autoimmune diseases, and serious cardiac disease; who have received continuous systemic steroids; who are pregnant, to be pregnant, or nursing mothers, and whom principle investigator or co-investigator judged to be inappropriate to participate in this study. |
Related Information
Primary Sponsor | Yokohama City University Hospital |
---|---|
Secondary Sponsor | Shinyokohama medical clinic |
Source(s) of Monetary Support | Medinet Co.,Ltd. |
Secondary ID(s) |
Contact
public contact | |
Name | |
Address | 3-9 Fukuura,Kanazawa-ku,Yokohama,Japan Japan |
Telephone | 045-787-2650 |
Affiliation | Yokohama City University Hospital Department of Gastroenterological Surgery |
scientific contact | |
Name | Yasushi Ichikawa |
Address | 3-9 Fukuura,Kanazawa-ku,Yokohama,Japan Japan |
Telephone | 045-787-2650 |
Affiliation | Yokohama City University Hospital Department of Gastroenterological Surgery |